Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 우메모또 요시마사, 다께다야꾸힝고오교 가부시끼가이샤filedCritical우메모또 요시마사
Publication of KR900007438ApublicationCriticalpatent/KR900007438A/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
내용 없음No content
Description
일본뇌염 백신 및 그의 제조방법Japanese encephalitis vaccine and preparation method thereof
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.
Claims (2)
일본뇌염 비루스 감염 생쥐뇌 유제에서 얻어지는 비루스 부유액을, 안정화제의 공존하에, 소수성 한외여과막으로 회분여과하고, 비루스 불활성화 처리후, 강알칼리로 처리한 한외여과막으로 회분여과하는 것을 특징으로 하는 일본뇌염 백신의 제조방법.Japanese encephalitis vaccine characterized in that the antiviral suspension obtained from mouse encephalitis of Japanese encephalitis virus is batch filtered with a hydrophobic ultrafiltration membrane in the presence of a stabilizer, and then filtered by an ultrafiltration membrane treated with strong alkali after the virus inactivation treatment. Manufacturing method.단백질 함량 20㎍/ml 당의 역가가, 103이상인 일본 뇌염 백신.Japanese encephalitis vaccine having a titer of 20 µg / ml protein content of 10 3 or more.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019890016214A1988-11-101989-11-09
Japanese encephalitis vaccine and preparation method thereof
KR900007438A
(en)